CINRYZE: Clinical Trials

4 trials of CINRYZE, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 unknown. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Recruiting 1, Unknown 1

Follow CINRYZE: new trials by email Literature Review of CINRYZE trials Research Report on CINRYZE

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Complement Inhibition: Attacking the Overshooting Inflammation @Fter Subarachnoid Hemorrhage (CIAO@SAH)
C1 Esterase Inhibitor Injection [Cinryze], Placebo - Subarachnoid Hemorrhage, Aneurysmal
Phase 2RecruitingHaaglanden Medical Centre1282024-11-042024-12-27
Complement Inhibition: Attacking the Overshooting Inflammation @Fter Traumatic Brain Injury
C1 Inhibitor, Human, Placebo - Traumatic Brain Injury, Trauma, Head
Phase 2UnknownLeiden University Medical Center1062021-02-252021-09-13
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration
CINRYZE - Hereditary Angioedema
Phase 2CompletedShire262010-06-072021-07-09
CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12
CINRYZE - Hereditary Angioedema (HAE)
Phase 2CompletedShire92010-06-022021-06-03

Conditions studied

Angioedemas, Hereditary (3)  ·  Brain Injuries, Traumatic (1)  ·  Craniocerebral Trauma (1)  ·  Neuroinflammatory Diseases (1)  ·  Subarachnoid Hemorrhage (1)

Sponsors

Shire (2)  ·  Haaglanden Medical Centre (1)  ·  Leiden University Medical Center (1)

Countries

Netherlands (2)  ·  United States (2)  ·  Germany (1)  ·  Hungary (1)

Top investigators

Wilco Peul, MD, MPH, PhD, MBa (1)  ·  Wouter Moojen, MD PHD (1)

Results publications

PMID 26171584, PMID 34863258